ALL YOU NEED IS AIR
DEAD

Serial Number

90501580

Owner

BEYOND AIR, INC.

Attorney

Laura J. Winston

Filing Date

Feb 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ALL YOU NEED IS AIR Trademark

Serial Number: 90501580

ALL YOU NEED IS AIR is a trademark filed by BEYOND AIR, INC. on February 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BEYOND AIR, INC. (14 trademarks)

900 Stewart Avenue, Suite 301
Garden City, NY 11530

Entity Type: 03

Trademark Details

Filing Date

February 1, 2021

Registration Date

Not Registered

Published for Opposition

August 2, 2022

Goods & Services

Scientific study and research in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; new product design for others in the field of scientific research in tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research for medical purposes in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medical research services, namely conducting clinical trials for others; scientific research on the use of nitric oxide for medical purposes for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research on developing pharmaceutical preparations and treatments for respiratory diseases

Medical apparatus and instruments, namely, therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit to be used at home or in a hospital; diagnostic, examination, and monitoring equipment, namely, medical apparatus and instruments for diagnosing and monitoring tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medical diagnostic apparatus for detecting tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; patient medical monitors for monitoring tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; medical apparatus in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; medical apparatus in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit delivered to patients, featuring the setting, measuring, and regulating of such mixture of medical and therapeutic gases

Pharmaceutical preparations and articles, namely, cartridges sold pre-filled with gas mixtures for medical use at home or in a hospital; cartridges sold pre-filled with gases, namely, nitric oxide, for medical use; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; drugs for medical purposes, namely, pharmaceutical preparations for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medicines for human purposes for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 3, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 3, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2025 EXRA
SOU EXTENSION 5 GRANTED
Jul 7, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 7, 2025 AITU
SOU TEAS EXTENSION RECEIVED
Mar 11, 2025 EEXT
SOU EXTENSION 5 FILED
Mar 10, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2024 EXRA
SOU EXTENSION 4 GRANTED
Sep 25, 2024 EX4G
SOU EXTENSION 4 FILED
Sep 25, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 25, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 10, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 10, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2024 EXRA
SOU EXTENSION 3 GRANTED
Mar 15, 2024 EX3G
SOU EXTENSION 3 FILED
Mar 15, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 15, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 6, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 6, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 22, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 22, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2023 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 27, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 11, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 25, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 25, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 25, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2021 NWOS
NEW APPLICATION ENTERED
Feb 4, 2021 NWAP